Clinical Research Services Market: By Type of Service, By Disease Area, By End User and Region Forecast 2019-2030

download arrow download arrow Download Free Sample
settings arrow settings arrow email us

Clinical Research Services Market Size, Share, Growth, Trends, and Global Industry Analysis: By Type of Service (Treatment Research, Prevention Research, Diagnostic Research, Screening Research, Quality of Life Research, Genetic studies, Epidemiological studies, Clinical Trials, Others), By Disease Area (Oncology, Central Nervous System Disorders, Cardio Vascular Disorders, Diabetes, Infectious Diseases, Others), By End User (Pharmaceutical Companies, Biotechnological Companies, Research Organizations, Others) and Region Forecast 2019-2030

checked icon arrow_drop_down
checked icon Single User License $4400 $3520
checked icon Multiple User License $6600 $5280
checked icon Corporate User License $8900 $7120

Clinical research services market size was valued at US$ 47.06 billion in 2023 and is poised to grow at a CAGR of 9.41% from 2024-2030. Clinical research is a branch of healthcare that studies whether a medical strategy, medicine, medical device, diagnostics and treatment regimes is safe and effective for human use. Clinical research may contribute to treatment, prevention, diagnosis or relieving certain symptoms of disease or condition. Clinical research is carried out with a pool of patients or people under study condition. Clinical research is a broad term which includes many research studies such as treatment, prevention, diagnostic, screening, genetic, epidemiological and clinical trial studies. the market is at steady stage of growth. The market is expected to grow at a significant rate during the forecast period. Market players are expanding their markets by offering various services and collaborations.

Key Developments

  • In June 2017, PAREXEL International Corporation, a leading global biopharmaceutical services organization, collaborated with Sanofi to advance the use of wearable devices to transform the collection of data in clinical trials.
  • In May, 2017 and inVentiv Health, Inc. and INC Research Holdings, Inc., announced a definitive merger agreement to create a leading biopharmaceutical solutions organization.
  • In April 2016, Charles River Laboratories acquired WIL Research to enhance its global footprint, scientific capabilities, and access to growing market segments.

summary download arrow Download Free Sample

Clinical Research Services Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

9.4%

Largest Market

Asia Pacific

Fastest Growing Market

North America

Clinical Research Services Market Dynamics

Global market is driven by increased burden of chronic diseases such as HIV, cancer and cardio vascular diseases, which requires huge investments. Pharmaceutical and biotechnological companies outsource their clinical research activities to clinical research service organizations to reduce the cost and regulatory burdens. In addition, enormous growth in biopharmaceutical segment, discovery of the new drugs through innovation and increase in clinical trials are expected to boost the  market over the forecast period. However, increase in clinical research costs, stringent regulatory procedures and ethical issues are hindering the market.

Clinical Research Services Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2024-2030

Market Size in 2023

US$ 47.06 billion

Market CAGR

9.4%

By Type of Service

  • Treatment Research,
  • Prevention Research,
  • Diagnostic Research,
  • Screening Research,
  • Quality of Life Research,
  • Genetic studies,
  • Epidemiological studies,
  • Clinical Trials,
  • Others

By Disease Area

  • Oncology,
  • Central Nervous System Disorders,
  • Cardio Vascular Disorders,
  • Diabetes,
  • Infectious Diseases,
  • Others

By End User

  • Pharmaceutical Companies,
  • Biotechnological Companies,
  • Research Organizations,
  • Others

By Region

  • North America (U.S., Canada)
  • Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
  • Asia-Pacific (China, India, Japan, Australia, Southeast Asia, Rest of Asia Pacific)
  • Latin America (Mexico, Brazil, Argentina, Columbia, Rest of Latin America)
  • Middle East & Africa (GCC, Egypt, Nigeria, South Africa, Rest of Middle East and Africa)

Key Features of the Report

  • The clinical research services market report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter's Five Force Analysis 

Download Free Sample Report

I accept the Terms and Conditions,Disclaimers, GDPR Policy

Frequently Asked Questions

The Clinical Research Services Market size was valued at US$ 47.06 billion in 2023 and is poised to grow at a CAGR of 9.41% from 2024-2030.

Quintiles Transnational Holdings Inc. (U.S.), PAREXEL International Corporation (U.S.), ICON Plc (Ireland), PRA Health Sciences, Inc. (U.S.), InVentiv Health Inc. (U.S.), Wuxi AppTec (Cayman) Inc. (China)

North America is the fastest-growing region for the market.

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

1.Executive Summary
2.Global Clinical Research Services Market Introduction 
2.1.Global Clinical Research Services Market  - Taxonomy
2.2.Global Clinical Research Services Market  - Definitions
2.2.1.Type of Service
2.2.2.Disease Area 
2.2.3. End User
2.2.4.Region
3.Global Clinical Research Services Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Clinical Research Services Market Analysis, 2019 - 2023 and Forecast 2024 - 2030
4.1.  Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Clinical Research Services Market  By Type of Service, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
5.1. Treatment Research,
5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Prevention Research,
5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Diagnostic Research,
5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Screening Research,
5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
5.5. Quality of Life Research,
5.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.5.3. Market Opportunity Analysis 
5.6. Genetic studies,
5.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.6.3. Market Opportunity Analysis 
5.7. Epidemiological studies,
5.7.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.7.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.7.3. Market Opportunity Analysis 
5.8. Clinical Trials,
5.8.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.8.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.8.3. Market Opportunity Analysis 
5.9. Others
5.9.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
5.9.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.9.3. Market Opportunity Analysis 
6.Global Clinical Research Services Market  By Disease Area, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
6.1. Oncology,
6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Central Nervous System Disorders,
6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Cardio Vascular Disorders,
6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Diabetes,
6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
6.5. Infectious Diseases,
6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.5.3. Market Opportunity Analysis 
6.6. Others
6.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
6.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.6.3. Market Opportunity Analysis 
7.Global Clinical Research Services Market  By  End User, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
7.1. Pharmaceutical Companies,
7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Biotechnological Companies,
7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Research Organizations,
7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Others
7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
8.Global Clinical Research Services Market  By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Europe
8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Asia Pacific (APAC)
8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Middle East and Africa (MEA)
8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Latin America
8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9.North America Clinical Research Services Market, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
9.1. Type of Service Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Treatment Research,
9.1.2.Prevention Research,
9.1.3.Diagnostic Research,
9.1.4.Screening Research,
9.1.5.Quality of Life Research,
9.1.6.Genetic studies,
9.1.7.Epidemiological studies,
9.1.8.Clinical Trials,
9.1.9.Others
9.2.  Disease Area  Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Oncology,
9.2.2.Central Nervous System Disorders,
9.2.3.Cardio Vascular Disorders,
9.2.4.Diabetes,
9.2.5.Infectious Diseases,
9.2.6.Others
9.3.   End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Pharmaceutical Companies,
9.3.2.Biotechnological Companies,
9.3.3.Research Organizations,
9.3.4.Others
9.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.4.1.United States of America (USA)
9.4.2.Canada
10.Europe Clinical Research Services Market, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
10.1. Type of Service Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Treatment Research,
10.1.2.Prevention Research,
10.1.3.Diagnostic Research,
10.1.4.Screening Research,
10.1.5.Quality of Life Research,
10.1.6.Genetic studies,
10.1.7.Epidemiological studies,
10.1.8.Clinical Trials,
10.1.9.Others
10.2.  Disease Area  Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Oncology,
10.2.2.Central Nervous System Disorders,
10.2.3.Cardio Vascular Disorders,
10.2.4.Diabetes,
10.2.5.Infectious Diseases,
10.2.6.Others
10.3.   End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Pharmaceutical Companies,
10.3.2.Biotechnological Companies,
10.3.3.Research Organizations,
10.3.4.Others
10.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Germany
10.4.2.France
10.4.3.Italy
10.4.4.United Kingdom (UK)
10.4.5.Spain
11.Asia Pacific (APAC) Clinical Research Services Market, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
11.1. Type of Service Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Treatment Research,
11.1.2.Prevention Research,
11.1.3.Diagnostic Research,
11.1.4.Screening Research,
11.1.5.Quality of Life Research,
11.1.6.Genetic studies,
11.1.7.Epidemiological studies,
11.1.8.Clinical Trials,
11.1.9.Others
11.2.  Disease Area  Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Oncology,
11.2.2.Central Nervous System Disorders,
11.2.3.Cardio Vascular Disorders,
11.2.4.Diabetes,
11.2.5.Infectious Diseases,
11.2.6.Others
11.3.   End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Pharmaceutical Companies,
11.3.2.Biotechnological Companies,
11.3.3.Research Organizations,
11.3.4.Others
11.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.China
11.4.2.India
11.4.3.Australia and New Zealand (ANZ)
11.4.4.Japan
11.4.5.Rest of APAC
12.Middle East and Africa (MEA) Clinical Research Services Market, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
12.1. Type of Service Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Treatment Research,
12.1.2.Prevention Research,
12.1.3.Diagnostic Research,
12.1.4.Screening Research,
12.1.5.Quality of Life Research,
12.1.6.Genetic studies,
12.1.7.Epidemiological studies,
12.1.8.Clinical Trials,
12.1.9.Others
12.2.  Disease Area  Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Oncology,
12.2.2.Central Nervous System Disorders,
12.2.3.Cardio Vascular Disorders,
12.2.4.Diabetes,
12.2.5.Infectious Diseases,
12.2.6.Others
12.3.   End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Pharmaceutical Companies,
12.3.2.Biotechnological Companies,
12.3.3.Research Organizations,
12.3.4.Others
12.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.GCC Countries
12.4.2.South Africa
12.4.3.Rest of MEA
13.Latin America Clinical Research Services Market, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million)
13.1. Type of Service Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Treatment Research,
13.1.2.Prevention Research,
13.1.3.Diagnostic Research,
13.1.4.Screening Research,
13.1.5.Quality of Life Research,
13.1.6.Genetic studies,
13.1.7.Epidemiological studies,
13.1.8.Clinical Trials,
13.1.9.Others
13.2.  Disease Area  Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Oncology,
13.2.2.Central Nervous System Disorders,
13.2.3.Cardio Vascular Disorders,
13.2.4.Diabetes,
13.2.5.Infectious Diseases,
13.2.6.Others
13.3.   End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Pharmaceutical Companies,
13.3.2.Biotechnological Companies,
13.3.3.Research Organizations,
13.3.4.Others
13.4.  Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Brazil
13.4.2.Mexico
13.4.3.Rest of LA
14. Competition Landscape
14.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
14.2.1.Laboratory Corporation Of America Holdings (U.S.)
14.2.2.Quintiles Transnational Holdings Inc. (U.S.)
14.2.3.PAREXEL International Corporation (U.S.)
14.2.4.ICON Plc (Ireland)
14.2.5.PRA Health Sciences, Inc. (U.S.)
14.2.6.InVentiv Health Inc. (U.S.)
14.2.7.Wuxi AppTec (Cayman) Inc. (China)
14.2.8.Pharmaceutical Product Development, LLC (U.S.)
14.2.9.INC Research Holdings Inc. (U.S.)
14.2.10.Charles River Laboratories International Inc. (U.S.)
15. Research Methodology 
16. Appendix and Abbreviations 

Key Market Players

  • Laboratory Corporation Of America Holdings (U.S.)
  • Quintiles Transnational Holdings Inc. (U.S.)
  • PAREXEL International Corporation (U.S.)
  • ICON Plc (Ireland)
  • PRA Health Sciences, Inc. (U.S.)
  • InVentiv Health Inc. (U.S.)
  • Wuxi AppTec (Cayman) Inc. (China)
  • Pharmaceutical Product Development, LLC (U.S.)
  • INC Research Holdings Inc. (U.S.)
  • Charles River Laboratories International Inc. (U.S.)

Related Industry Reports

Cardiovascular Drugs Market

Global Diagnostic Imaging Market

Clinical Research Services Market

Global Atopic Dermatitis Treatment Market